Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathology.

Cellยท2026
Same author

Web engine for tumor pathology image retrievals on massive scales.

bioRxiv : the preprint server for biologyยท2025
Same author

Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy.

Cellยท2025
Same author

GPRC5A promotes lung colonization of esophageal squamous cell carcinoma.

Nature communicationsยท2024
Same author

Identification and Characterization of Metastasis-Initiating Cells in ESCC in a Multi-Timepoint Pulmonary Metastasis Mouse Model.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)ยท2024
Same author

Estimation of cell lineages in tumors from spatial transcriptomics data.

Nature communicationsยท2023

Related Experiment Video

Updated: Oct 8, 2025

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
12:36

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

9.6K

Discover immunotherapy biomarkers from single-cell cytometry data.

Beibei Ru1, Peng Jiang1

  • 1Cancer Data Science Lab, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Patterns (New York, N.Y.)
|December 24, 2021
PubMed
Summary

Identifying new biomarkers is vital for cancer immunotherapy. Researchers developed FAUST, an interpretable machine learning method using single-cell cytometry data, to find cell populations linked to patient outcomes.

More Related Videos

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.3K
A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
09:34

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

6.8K

Related Experiment Videos

Last Updated: Oct 8, 2025

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
12:36

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

9.6K
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.3K
A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
09:34

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

6.8K

Area of Science:

  • Immunology
  • Bioinformatics
  • Computational Biology

Background:

  • Identifying novel biomarkers is essential for advancing cancer immunotherapy.
  • Single-cell cytometry generates high-dimensional data for analyzing cellular heterogeneity.

Discussion:

  • The study introduces FAUST, a novel interpretable machine learning approach.
  • FAUST utilizes single-cell cytometry data to identify cell populations associated with clinical outcomes.
  • Interpretability of the machine learning model is a key feature.

Key Insights:

  • FAUST successfully discovers cell populations relevant to cancer immunotherapy outcomes.
  • The method provides insights into the cellular basis of treatment response.
  • This approach enhances the discovery of predictive biomarkers.

Outlook:

  • FAUST has the potential to accelerate biomarker discovery in oncology.
  • Further validation and application of FAUST in diverse cancer types are warranted.
  • This work contributes to the development of precision medicine in cancer treatment.